mantle cell lymphoma
Amneal Launches Boruzu for Multiple Myeloma and Mantle Cell Lymphoma
Amneal Pharmaceuticals Inc. and Shilpa Medicare Limited announced the U.S. launch of Boruzu, a new presentation of ...
APRIL 4, 2025
FDA Approves Calquence With Bendamustine and Rituximab for Previously Untreated Mantle Cell Lymphoma
The FDA has granted traditional approval to Calquence with bendamustine and rituximab for adults with previously ...
JANUARY 21, 2025
Jaypirca Approved for Relapsed or Refractory Mantle Cell Lymphoma
The FDA granted accelerated approval to Jaypirca for relapsed or refractory MCL after at least two lines of ...
FEBRUARY 13, 2023
Tecartus Approved as First CAR T-Cell Therapy for Mantle Cell Lymphoma
The FDA approved the chimeric antigen receptor (CAR) T-cell therapy brexucabtagene autoleucel (Tecartus, Kite) for ...
JULY 28, 2020
FDA Approves BTK Inhibitor Calquence for Mantle Cell Lymphoma
The FDA granted accelerated approval to acalabrutinib (Calquence, AstraZeneca) for the treatment of adults with ...
NOVEMBER 1, 2017